CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-28 | Lapuerta Pablo EVP and CMO | Exercise or conversion · Restricted Stock Units | −8,570 | 17,140 | ||
| 2019-02-28 | COATS LONNEL President and CEO | Exercise or conversion | +10,835 | 68,914 | ||
| 2019-02-28 | COATS LONNEL President and CEO | Exercise or conversion | +8,390 | 77,304 | ||
| 2019-02-28 | COATS LONNEL President and CEO | Exercise or conversion | +5,363 | 82,667 | ||
| 2019-02-28 | COATS LONNEL President and CEO | Exercise or conversion | +23,513 | 106,180 | ||
| 2019-02-28 | COATS LONNEL President and CEO | Shares withheld for taxes | −18,641 | $5.51 | $103K | 87,539 |
| 2019-02-28 | COATS LONNEL President and CEO | Exercise or conversion · Restricted Stock Units | −10,835 | 0 | ||
| 2019-02-28 | COATS LONNEL President and CEO | Exercise or conversion · Restricted Stock Units | −8,390 | 8,390 | ||
| 2019-02-28 | COATS LONNEL President and CEO | Exercise or conversion · Restricted Stock Units | −5,363 | 10,725 | ||
| 2019-02-28 | COATS LONNEL President and CEO | Exercise or conversion · Restricted Stock Units | −23,513 | 47,027 | ||
| 2019-02-07 | Tessmer James F VP, Finance & Accounting | Grant or award · Stock Option (Right to Buy) | +39,770 | 39,770 | ||
| 2019-02-07 | Tessmer James F VP, Finance & Accounting | Grant or award · Restricted Stock Units | +26,510 | 26,510 | ||
| 2019-02-07 | TYLE PRAVEEN EVP, R&D | Grant or award · Stock Option (Right to Buy) | +148,200 | 148,200 | ||
| 2019-02-07 | TYLE PRAVEEN EVP, R&D | Grant or award · Restricted Stock Units | +79,800 | 79,800 | ||
| 2019-02-07 | Santini Alexander A EVP and CCO | Grant or award · Stock Option (Right to Buy) | +127,320 | 127,320 | ||
| 2019-02-07 | Santini Alexander A EVP and CCO | Grant or award · Restricted Stock Units | +68,560 | 68,560 | ||
| 2019-02-07 | MAIN ALAN J EVP, Commercial Supply Ops | Grant or award · Stock Option (Right to Buy) | +124,640 | 124,640 | ||
| 2019-02-07 | MAIN ALAN J EVP, Commercial Supply Ops | Grant or award · Restricted Stock Units | +67,120 | 67,120 | ||
| 2019-02-07 | Lapuerta Pablo EVP and CMO | Grant or award · Stock Option (Right to Buy) | +130,710 | 130,710 | ||
| 2019-02-07 | Lapuerta Pablo EVP and CMO | Grant or award · Restricted Stock Units | +70,390 | 70,390 |
Page 48 of 51 · 1,001 trades